Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have given their voluntary written agreement to participate (or whose legal representative has done so) before any screening begins
- Women aged 18 years or older
- People who have recently received their first-ever diagnosis of endometrial cancer (a type of uterine cancer), at any stage and of any type
Who may not be able to join:
- People who have previously had surgery to remove or sample lymph nodes in the pelvis or near the aorta (a major blood vessel in the abdomen), or who have had radiotherapy to those areas, or who have received chemotherapy before surgery
- People who have any condition that, in the treating doctor's opinion, could put them at risk or make it difficult to follow the trial's requirements
- People who are receiving, or have previously received, any other treatment that could affect their safety or interfere with the trial's results
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Frédéric Amant, MD, PhD, UZ Leuven Gasthuisberg
Phone: +3216342194
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Endometrial cancer stage; Molecular type of endometrial cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.